glp 1 latest news GLP-1 News: Updates on Weight Loss and Diabetes Medications Overdose risks increase as demand

Recently, the Food and Drug Administration officially approved semaglutide for the treatment of metabolic dysfunction-associated steatohepatitis in adults with moderate-to-advanced fibrosis

Learn about the latest science behind GLP-1 weight loss drugs, the nutritional needs of GLP-1 users and what this means for future innovation in food and beverage.

Discover practical strategies to reduce nausea and improve tolerability with GLP-1 medications for diabetes and weight management.

Metabolic Engineering activates the same pathway naturally without the side effects.

Learn the most common side effects of GLP-1 medications, like nausea, fatigue and reflux, and find tips to manage them effectively.